Cleared Traditional

K190907 - ZEUS ELISA Borrelia VlsE1/pepC10 IgG/Ig...

Also marketed or referenced as:
ZEUS ELISA Borrelia burgdorferi IgG/IgM Test System

K190907 is an FDA 510(k) clearance for ZEUS ELISA Borrelia VlsE1/pepC10 IgG/Ig..., manufactured by Zeus Scientific, Inc.. The device is a Class 2 Microbiology device with product code LSR cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K190907 · Zeus Scientific, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2019
Decision
112d
Days
Class 2
Risk

K190907 is an FDA 510(k) clearance for the ZEUS ELISA Borrelia VlsE1/pepC10 IgG/IgM Test System. Classified as Reagent, Borrelia Serological Reagent (product code LSR), Class II - Special Controls.

Submitted by Zeus Scientific, Inc. (Raritan, US). The FDA issued a Cleared decision on July 29, 2019 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3830 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Zeus Scientific, Inc. devices

FDA 510(k) Submission Details - K190907

510(k) Number K190907 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 2019
Decision Date July 29, 2019
Days to Decision 112 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 102d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LSR Device Classification - Class 2, Special Controls

Product Code LSR Reagent, Borrelia Serological Reagent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LSR Reagent, Borrelia Serological Reagent

All 59
Devices cleared under the same product code (LSR) and FDA review panel - the closest regulatory comparables to K190907.
Gold Standard Diagnostics Borrelia burgdorferi IgM ELISA Test Kit
K200023 · Gold Standard Diagnostics · Apr 2020
Gold Standard Diagnostics Borrelia burgdorferi IgG ELISA Test Kit
K200025 · Gold Standard Diagnostics · Apr 2020
LIAISON Lyme Total Antibody Plus, LIAISON Lyme Total Antibody Plus Control Set
K193051 · DiaSorin, Inc. · Jan 2020
ZEUS ELISA Borrelia VlsE1/pepC10 IgG/IgM Test System
K191240 · Zeus Scientific, Inc. · Jul 2019
ZEUS ELISA Borrelia VlsE1/pepC10 IgG/IgM Test System
K191398 · Zeus Scientific, Inc. · Jul 2019
BioPlex 2200 Lyme Total
K183446 · Bio-Rad Laboratories · Mar 2019